Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Anticancer Research|July 2, 2014
Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapyYosuke Morodomi, Mitsuhiro Takenoyama, Eiko Inamasu, et al.
BMC Cancer|December 5, 2020
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 studyTomoshi Tsuchiya, Ryotaro Kamohara, Masashi Muraoka, et al.
Thoracic Cancer|February 6, 2020
S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501Minoru Fukuda, Soichiro Funaki, Takuya Yamazaki, et al.
Thoracic Cancer|July 8, 2016
Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B)Minoru Fukuda, Takayuki Suetsugu, Midori Shimada, et al.
Anticancer Research|June 9, 2016
Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802)Kazuhiko Yamada, Koichi Azuma, Masafumi Takeshita, et al.
Surgical Case Reports|October 2, 2025
Pathological Complete Response in Locally Advanced ALK Fusion Gene-Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature ReviewKazuki Ohta, Naoki Haratake, Shinkichi Takamori, et al.
Anticancer Research|April 12, 2003
A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patientsTsunehiro Oyama, Toshihiro Kawamoto, Koji Matsuno, et al.
Anticancer Research|July 11, 2006
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growthMakiko Mizukami, Takeshi Hanagiri, Yoshiki Shigematsu, et al.
International Journal of Cancer|November 30, 2006
Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lungMasakazu Sugaya, Mitsuhiro Takenoyama, Yoshiki Shigematsu, et al.
Anticancer Research|September 16, 2016
The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung AdenocarcinomaGouji Toyokawa, Kenichi Taguchi, Makoto Edagawa, et al.
Pageof 19